Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperlucent lung secondary to homocystinuria

J Herman1, J H Miller, F Wang

  • 1University of California, Irvine Medical Center, Irvine, California, USA.

Pediatric Radiology
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential modulation of proliferation in the neocortical ventricular and subventricular zones.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2000
Same author

Preconditioning with cortical spreading depression decreases intraischemic cerebral glutamate levels and down-regulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebal cortex plasma membranes.

Journal of neurochemistry·2000
Same author

Proteomic analysis of the atrophying rat soleus muscle following denervation.

Electrophoresis·2000
Same author

Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1.

Biochemical and biophysical research communications·2000
Same author

Modelling the cumulative risk for a false-positive under repeated screening events.

Statistics in medicine·2000
Same author

Two-headed binding of a processive myosin to F-actin.

Nature·2000

This report describes monozygotic twins who presented with lung abnormalities caused by undiagnosed homocystinuria. The condition led to blood clots in the lungs, which were the first signs of the metabolic disorder. Clinicians should consider this rare disease when unexplained lung issues occur in children.

Area of Science:

  • Pulmonary medicine and hyperlucent lung diagnostics
  • Metabolic disorders within clinical genetics

Background:

No prior work had resolved the link between early-onset pulmonary vascular obstruction and metabolic errors in asymptomatic infants. It was already known that homocystinuria often presents with skeletal or ocular abnormalities. That uncertainty drove clinicians to investigate unusual respiratory findings in young patients. Prior research has shown that vascular complications are a hallmark of this inherited condition. This gap motivated a detailed examination of twins presenting with unilateral lung clarity. Researchers sought to understand how metabolic dysfunction triggers localized blood flow issues. No prior work had resolved why these patients lacked typical phenotypic markers. That uncertainty drove the need for comprehensive post-mortem and diagnostic evaluations.

Purpose Of The Study:

The aim of this study was to investigate the cause of unilateral hyperlucent lung in pediatric patients. Researchers sought to determine why these twins presented with severe respiratory issues without other symptoms. The team intended to establish a connection between unexplained lung clarity and metabolic dysfunction. This investigation was motivated by the need to understand the underlying pathology of pulmonary arterial thrombosis. The authors aimed to clarify the role of homocystinuria in early-onset vascular disease. They sought to document the clinical progression of this condition in monozygotic twins. This work was designed to provide diagnostic insights for clinicians encountering similar respiratory presentations. The researchers intended to highlight the importance of metabolic screening in cases of idiopathic lung defects.

Keywords:
metabolic disordersvascular thrombosispediatric respiratory diseaseventilation perfusion mismatch

Frequently Asked Questions

The researchers propose that pulmonary arterial thrombosis causes the ventilation-perfusion mismatch. This obstruction prevents proper gas exchange, leading to the observed hyperlucent lung appearance in the affected patients.

The authors utilized radionuclide ventilation/perfusion pulmonary scans to assess lung function. This imaging technique allowed the team to identify mismatched defects, which indicated significant blood flow blockages within the pulmonary vasculature.

The researchers state that the entire lung was affected in the deceased twin, while the survivor exhibited multiple distinct defects. This regional involvement confirms that the metabolic condition causes widespread vascular damage throughout the pulmonary system.

The team relied on autopsy findings to confirm the presence of pulmonary arterial thrombosis. These histological results provided the necessary evidence to link the observed vascular pathology directly to the underlying metabolic disorder.

Related Experiment Videos

Main Methods:

The review approach involved analyzing clinical data from monozygotic twins presenting with respiratory distress. Investigators performed radionuclide ventilation and perfusion scans to map lung function. These diagnostic procedures identified areas of impaired gas exchange. The team conducted a thorough autopsy on the deceased patient to examine internal tissues. Histological assessments confirmed the presence of vascular blockages. Clinicians compared the findings from the deceased twin with the surviving sibling. Medical records were scrutinized to identify any additional symptoms of the metabolic condition. This systematic evaluation allowed for a clear correlation between the respiratory symptoms and the underlying genetic disorder.

Main Results:

The strongest finding was the identification of pulmonary arterial thrombosis as the cause of the hyperlucent lung. Radionuclide scans revealed a complete ventilation-perfusion mismatch in the deceased twin. The surviving sibling displayed multiple mismatched defects, which the authors suggest indicate pulmonary embolism. Autopsy results confirmed histological changes consistent with homocystinuria in the deceased patient. Both twins lacked typical skeletal or ocular stigmata at the time of their initial presentation. The pulmonary thrombotic disease was the primary manifestation of the metabolic disorder in both cases. These results demonstrate that vascular obstruction can be the earliest sign of this condition. The data highlight a significant link between metabolic errors and severe lung pathology in infants.

Conclusions:

The authors propose that pulmonary thrombosis serves as a primary clinical indicator for homocystinuria. Synthesis and implications suggest that clinicians must screen for metabolic disorders in pediatric patients with unexplained lung defects. The researchers indicate that vascular events may precede other classic signs of the disease. Their findings imply that early detection of this metabolic error is vital for managing potential clotting risks. The authors suggest that ventilation and perfusion imaging can identify significant vascular obstructions. They conclude that homocystinuria should remain a differential diagnosis for children with atypical respiratory presentations. Their observations indicate that monozygotic twins may share identical clinical trajectories for this condition. The study implies that pulmonary vascular health is a critical aspect of metabolic monitoring.

The authors measured the ventilation-perfusion mismatch to quantify the severity of the lung damage. This specific measurement demonstrated that the metabolic disease significantly impairs the ability of the lungs to oxygenate blood effectively.

The researchers suggest that pulmonary thrombotic disease can be the initial manifestation of homocystinuria. This implication highlights the necessity of considering metabolic screening even when classic skeletal or ocular markers are absent.